Global Medical REIT (GMRE)
(Delayed Data from NYSE)
$6.50 USD
-0.25 (-3.70%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $6.48 -0.02 (-0.31%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
GMRE 6.50 -0.25(-3.70%)
Will GMRE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GMRE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMRE
Global Medical REIT (GMRE) Q2 FFO Meet Estimates
Global Medical REIT (GMRE) Q1 FFO Meet Estimates
GMRE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ashford Hospitality Trust (AHT) Reports Q1 Loss, Lags Revenue Estimates
Alexander's (ALX) Q1 FFO Beat Estimates
CubeSmart (CUBE) Tops Q1 FFO and Revenue Estimates
Other News for GMRE
Global Medical REIT Inc. (GMRE) Q2 2025 Earnings Call Transcript
YieldBoost GMRE To 41% Using Options
2 High-Yield Preferreds For Non-Cyclical Retirement Income
Global Medical REIT (GMRE) Reaffirms FY25 AFFO Projections
Global Medical REIT (GMRE) Exceeds Revenue Expectations in Q2